Search Results

SEATTLE, WA--(Marketwired - Sep 12, 2013) - The ForeCYTE Breast Health Test, the flagship product of Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, was featured in a video segment and article on FoxNews.com posted on September 11. The segment and article profiled Marci Dulgerian, a resident of Little Neck, NY who lost both her mother and grandmother to breast cancer, and who wants more information about her breast health

SEATTLE, WA--(Marketwired - Sep 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, will display its ForeCYTE Breast Health Test at the 7th annual Breast Cancer Symposiumfrom September 7 through September 9, 2013 in San Francisco

SEATTLE, WA--(Marketwired - Aug 22, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, will visit the NASDAQ MarketSite in Times Square to celebrate its listing on the NASDAQ Stock Market, which occurred on November 8, 2012. In honor of the occasion, Dr

SEATTLE, WA--(Marketwired - Aug 21, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Dr. Steven C.

SEATTLE, WA--(Marketwired - Aug 21, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS) and its subsidiary The National Reference Laboratory for Breast Health (NRLBH), will display their products and services at the Georgia Obstetrical and Gynecological Society 2013 Annual Meeting, August 22-25, in Greensboro, Georgia, and at the inaugural National Women's Survivors Convention, August 22-24, in Nashville, Tennessee. The ForeCYTE Breast Health Test, provided by the NRLBH, detects reversible precancerous conditions in the breast up to eight years before they become cancer.

SEATTLE, WA--(Marketwired - Aug 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, today announced the publication of a peer-reviewed paper titled "A phase I safety and efficacy study of the mammary aspirate specimen cytology test device for collection of specimens for exfoliative cytopathology of the breast ducts." The article was published in Advances in Bioscience and Biotechnology, 2013, 4, 846-852 ABB doi:10.4236/abb.2013.48112 Published Online August 2013 (http://www.scirp.org/journal/abb/)

SEATTLE, WA--(Marketwired - Aug 14, 2013) - Atossa Genetics, Inc.

SEATTLE, WA--(Marketwired - Aug 8, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, announced today that BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Atossa Genetics after releasing the latest short sale data through August 6, 2013. The total aggregate number of shares shorted since December 2012 is approximately 3.3 million shares

SEATTLE, WA--(Marketwired - Aug 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, today announced that it will issue financial results and corporate highlights for the quarter ended June 30, 2013, following the close of market on Wednesday, August 14, 2013. Management will host a conference call on Wednesday, August 14, 2013, at 4:45 pm Eastern time to review financial results and corporate highlights, including a slide presentation by Dr

SEATTLE, WA--(Marketwired - Jul 29, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, today announces its support for the fact that North Carolina has become the 12th state to pass a dense breast notification law, HB 467, the Breast Density Notification & Awareness bill. The bill was signed by Gov.

SEATTLE, WA--(Marketwired - Jul 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that the Company has been added to the Russell Microcap Index. The Russell Microcap Index measures the performance of the microcap segment of the U.S

SEATTLE, WA--(Marketwired - Jul 2, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Michael H. Kalnoski, M.D., has joined the Company as Medical Director, a newly created position

SEATTLE, WA--(Marketwired - Jun 26, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, today announced that Kyle Guse, CFO and General Counsel, will be presenting at two upcoming investor conferences: the JMP Securities Healthcare Conference in New York City and the Life Science Innovation Northwest 2013 Conference in Seattle. The JMP Securities Healthcare Conference presentation will take place on Tuesday, July 9, 2013, at 2:00 pm Eastern Time at the St.

SEATTLE, WA--(Marketwired - Jun 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, has signed an agreement with Fisher HealthCare Inc., part of Thermo Fisher Scientific, for distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits

SEATTLE, WA--(Marketwired - Jun 17, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, has entered into a contractual agreement with HealthSmart, a Preferred Provider Organization (PPO) network serving clients in all 50 states. The agreement with HealthSmart affords preferred providers and their patients with greater access to Atossa'sForeCYTE Breast Health Test by ensuring timely reimbursement for the laboratory costs associated with the test

SEATTLE, WA--(Marketwired - Jun 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Peter J

SEATTLE, WA--(Marketwired - May 29, 2013) - Atossa Genetics, Inc.

SEATTLE, WA--(Marketwired - May 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, will display its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, from May 31 through June 4, 2013

SEATTLE, WA--(Marketwired - May 21, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, is sponsoring two screenings of the new film Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013. Based on true events, Decoding Annie Parker follows a 15-year war waged on both scientific and emotional fronts by a pair of women demonstrating extreme bravery under pressure

SEATTLE, WA--(Marketwired - May 20, 2013) - Atossa Genetics, Inc.

SEATTLE, May 17, 2013 /PRNewswire/ --Atossa Genetics, Inc. (ATOS), The Breast Health Company, announced today that Kyle Guse, Chief Financial Officer & General Counsel, will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in New York City at the Grand Hyatt Hotel

SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak and participate on the Diagnostics panel at the Sachs Associates Cancer Bio Partnering Forum on Wednesday, May 22, 2013, at the Westin Copley Place in Boston, Massachusetts.

SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, today announced its first quarter 2013 financial results and corporate developments. "The national rollout of our ForeCYTE Breast Health Test is proceeding well and we are pleased with the response we are getting from the physician community and from patients," stated Dr

GARDEN CITY, N.Y., May 2, 2013 /PRNewswire/ --Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc

SEATTLE, WA--(Marketwired - May 2, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the distribution by Millennium Medical Devices of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits